Cargando…

Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly

Background and Objectives: Despite the best efforts of healthcare workers and the deployment of alternative healthcare delivery solutions through telemedicine, the pandemic has disrupted standard care for patients with chronic conditions. The long-lasting pandemic has also had a profound impact on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Herman, Rok, Janež, Andrej, Goričar, Katja, Rizzo, Manfredi, Jensterle, Mojca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783534/
https://www.ncbi.nlm.nih.gov/pubmed/36556914
http://dx.doi.org/10.3390/medicina58121711
_version_ 1784857600077070336
author Herman, Rok
Janež, Andrej
Goričar, Katja
Rizzo, Manfredi
Jensterle, Mojca
author_facet Herman, Rok
Janež, Andrej
Goričar, Katja
Rizzo, Manfredi
Jensterle, Mojca
author_sort Herman, Rok
collection PubMed
description Background and Objectives: Despite the best efforts of healthcare workers and the deployment of alternative healthcare delivery solutions through telemedicine, the pandemic has disrupted standard care for patients with chronic conditions. The long-lasting pandemic has also had a profound impact on the quality of life (QoL) of the majority of patients with chronic illnesses. The management of rare diseases has been particularly challenging. We aimed to evaluate the impacts that the long-lasting pandemic had on the disease control status and QoL in patients with acromegaly. Materials and Methods: Our prospective study included 34 patients from a national referral centre. The baseline SAGIT and AcroQoL results were obtained in October 2020 during the lockdown period of the SARS-CoV2 pandemic. The follow-up results were assessed during the summer of 2022 in a period without any public health restrictions. All the patients were additionally evaluated for their attitude towards preventative public health measures against SARS-CoV2 spread and required mask wearing during the pandemic. Results: By comparing assessments in 2020 during the lockdown period and 2022 post-lockdown, we observed some improvement in SAGIT subscores T and I, most likely reflecting treatment changes in a small number of patients. The global SAGIT score remained stable. QoL measurement by AcroQoL did not demonstrate any changes. There was a negative correlation between SAGIT subscore S and the AcroQoL results. We also noted that the group of patients with the most negative attitude toward public health measurements for preventing SARS-CoV2 spread had higher AcroQoL results than others. Conclusion: Our results showcase that the SARS-CoV2 pandemic, lasting over two years, did not impact the disease control status and QoL in patients with acromegaly. The cohort continued to be well controlled and without changes in QoL. We measured a relatively favourable attitude towards the public health measures to prevent the spread of SARS-CoV2; in particular, patients who had a lower QoL had more positive attitudes towards these measures.
format Online
Article
Text
id pubmed-9783534
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97835342022-12-24 Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly Herman, Rok Janež, Andrej Goričar, Katja Rizzo, Manfredi Jensterle, Mojca Medicina (Kaunas) Article Background and Objectives: Despite the best efforts of healthcare workers and the deployment of alternative healthcare delivery solutions through telemedicine, the pandemic has disrupted standard care for patients with chronic conditions. The long-lasting pandemic has also had a profound impact on the quality of life (QoL) of the majority of patients with chronic illnesses. The management of rare diseases has been particularly challenging. We aimed to evaluate the impacts that the long-lasting pandemic had on the disease control status and QoL in patients with acromegaly. Materials and Methods: Our prospective study included 34 patients from a national referral centre. The baseline SAGIT and AcroQoL results were obtained in October 2020 during the lockdown period of the SARS-CoV2 pandemic. The follow-up results were assessed during the summer of 2022 in a period without any public health restrictions. All the patients were additionally evaluated for their attitude towards preventative public health measures against SARS-CoV2 spread and required mask wearing during the pandemic. Results: By comparing assessments in 2020 during the lockdown period and 2022 post-lockdown, we observed some improvement in SAGIT subscores T and I, most likely reflecting treatment changes in a small number of patients. The global SAGIT score remained stable. QoL measurement by AcroQoL did not demonstrate any changes. There was a negative correlation between SAGIT subscore S and the AcroQoL results. We also noted that the group of patients with the most negative attitude toward public health measurements for preventing SARS-CoV2 spread had higher AcroQoL results than others. Conclusion: Our results showcase that the SARS-CoV2 pandemic, lasting over two years, did not impact the disease control status and QoL in patients with acromegaly. The cohort continued to be well controlled and without changes in QoL. We measured a relatively favourable attitude towards the public health measures to prevent the spread of SARS-CoV2; in particular, patients who had a lower QoL had more positive attitudes towards these measures. MDPI 2022-11-23 /pmc/articles/PMC9783534/ /pubmed/36556914 http://dx.doi.org/10.3390/medicina58121711 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Herman, Rok
Janež, Andrej
Goričar, Katja
Rizzo, Manfredi
Jensterle, Mojca
Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly
title Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly
title_full Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly
title_fullStr Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly
title_full_unstemmed Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly
title_short Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly
title_sort impact of covid-19 pandemic on disease control status and quality of life of patients with acromegaly
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783534/
https://www.ncbi.nlm.nih.gov/pubmed/36556914
http://dx.doi.org/10.3390/medicina58121711
work_keys_str_mv AT hermanrok impactofcovid19pandemicondiseasecontrolstatusandqualityoflifeofpatientswithacromegaly
AT janezandrej impactofcovid19pandemicondiseasecontrolstatusandqualityoflifeofpatientswithacromegaly
AT goricarkatja impactofcovid19pandemicondiseasecontrolstatusandqualityoflifeofpatientswithacromegaly
AT rizzomanfredi impactofcovid19pandemicondiseasecontrolstatusandqualityoflifeofpatientswithacromegaly
AT jensterlemojca impactofcovid19pandemicondiseasecontrolstatusandqualityoflifeofpatientswithacromegaly